C18H26F3N3O5 — CID 155860725
(1S,3aR,7aR)-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-5-(oxan-4-yl)-3,3a,4,6,7,7a-hexahydro-1H-furo[3,4-c]pyridine;2,2,2-trifluoroacetic acid (PubChem CID 155860725) has the molecular formula C18H26F3N3O5 and a molecular weight of 421.42 g/mol. Its IUPAC name is (1S,3aR,7aR)-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-5-(oxan-4-yl)-3,3a,4,6,7,7a-hexahydro-1H-furo[3,4-c]pyridine;2,2,2-trifluoroacetic acid.
| Compound Name | (1S,3aR,7aR)-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-5-(oxan-4-yl)-3,3a,4,6,7,7a-hexahydro-1H-furo[3,4-c]pyridine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 155860725 |
| Molecular Formula | C18H26F3N3O5 |
| Molecular Weight | 421.42 g/mol |
| Exact Mass | 421.18 |
| IUPAC Name | (1S,3aR,7aR)-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-5-(oxan-4-yl)-3,3a,4,6,7,7a-hexahydro-1H-furo[3,4-c]pyridine;2,2,2-trifluoroacetic acid |
| SMILES | Cc1nnc(C[C@@H]2OC[C@H]3CN(C4CCOCC4)CC[C@H]32)o1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C16H25N3O3.C2HF3O2/c1-11-17-18-16(22-11)8-15-14-2-5-19(9-12(14)10-21-15)13-3-6-20-7-4-13;3-2(4,5)1(6)7/h12-15H,2-10H2,1H3;(H,6,7)/t12-,14-,15+;/m1./s1 |
| InChIKey | XOECGPDLLQCDFP-LJGQPXTLSA-N |
| XLogP | 2.07 |
| TPSA | 97.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.42 |
| LogP ≤ 5 | 2.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |